Dr. Kessler is a Davee Professor of Stem Cell Biology at the Department of Neurology, Northwestern University. He was Chairman of Neurology at Northwestern for 12 years and currently is the director of its Stem Cell Institute. The majority of his research has focused on basic cellular and molecular neurobiology with the long-term goal of developing techniques for repairing the damaged nervous system. While serving as the Editor-in-Chief of the Annals of Clinical and Translational Neurology and an Associate Editor on several other journals, Dr. Kessler is also on the board of directors of two hospitals and numerous scientific advisory boards, including as an unpaid consultant to Helixmith.
Dr. Perin has been serving as the Medical Director of the Texas Heart Institute since April 2018. He has provided leadership at the THI for over 25 years, most recently as Director of Clinical Research, and is an alumni of the THI Cardiovascular Disease and Interventional Cardiology Fellowship programs. Dr. Perin is an interventional cardiologist in his private practice and has been continually ranked within the top 1% of all interventional cardiologists in the United States. He is the Director of Interventional Cardiology at BSLMC and Medical Director of the cardiac catheterization laboratories at BSLMC.
Dr. Scribner is a board-certified internist with postdoctoral training in immunology and rheumatology. He worked for the Center for Biologics Evaluation and Research for 10 years reviewing all facets of drug development in a wide variety of biologic products (cells, gene therapy, blood, plasma, recombinant products). He has more than 25 additional years of experience in venture-based drug development and in regulatory, clinical, and strategic product development consulting.
Dr. Katz is a neurologist and pain management specialist who has worked at Harvard Medical School, Brigham & Women’s Hospital and Dana Farber Cancer Institute, and served as Chair of the Advisory Committee, Anesthesia, Critical Care, and Addiction Products Division at the US FDA. Dr. Katz founded Analgesic Solutions with the mission of modernizing the design and conduct of pain clinical trials. He holds the positions of Chief Science Officer at WCG Analgesic Solutions and Adjunct Associate Professor of Anesthesia at Tufts School of Medicine. He was an Associate Editor at the Clinical Journal of Pain, and Associate Editor (Pain) for the Encyclopedia of Neurological Sciences.
Dr. Gudin is a Clinical Associate Professor of Anesthesiology at the Rutgers New Jersey Medical School, and Board Certified in Pain Management, Anesthesiology, Addiction Medicine and Hospice and Palliative Medicine. Until recently, and for the past 19 years, Dr. Gudin was Director of Pain Management and Palliative Care at the Englewood Hospital and Medical Center in NJ. He completed his residency in Anesthesiology at the Yale University School of Medicine and his fellowship at The Yale Center for Pain Management. He is co-Editor-in-Chief of Practical Pain Management journal. Dr. Gudin remains active in teaching and research and has lectured internationally on a variety of topics in pain management, palliative care and addiction medicine.